Safety Study of 5-Azacitidine and Standard Donor Lymphocyte Infusion (DLI) to Treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell Transplantation
PHASE2
This open label phase-II trial evaluates hematological response of an addit...
Status
Completed
Location
Universitaetsklinik Heidelberg, Medizinische Klinik und Poliklinik V
A Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combination With Venetoclax and Azacitidine in R/R Acute Myeloid Leukemia and Treatment-naïve Participants Not Eligible for Intensive Therapy
PHASE1
CC-90011-AML-002 is a Phase 1/2, open-label, multicenter study to assess th...
Study to Evaluate Adverse Events and Movement of Lemzoparlimab in Body When Used Intravenously (IV) With Azacitidine Subcutaneously or IV and Venetoclax Orally in Participants With Acute Myeloid Leukemia and With Azacitidine With or Without Venetoclax in Participants With Myelodysplastic Syndrome
PHASE1
Acute myeloid leukemia (AML) is one of the most aggressive blood cancers, w...
Status
Terminated
Location
University of Alabama at Birmingham - Main /ID# 227071